Colorectal cancer chemoprevention—an overview of the science1 1This article was prepared in our capacity as employees of the U.S. Federal Government.
Authors:
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 126 (5) , 1423-1447
Abstract
No abstract availableKeywords
This publication has 205 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Potential Pitfalls in the Use of Surrogate Endpoints in Colorectal Adenoma ChemopreventionJNCI: Journal of the National Cancer Institute, 2003
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Analysis of K-ras, APC, and β-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposisGastroenterology, 2001
- Biomarkers as surrogates for cancer development.Current Oncology Reports, 2000
- DNA hypermethylation in tumorigenesis: epigenetics joins geneticsTrends in Genetics, 2000
- The Hallmarks of CancerCell, 2000
- Genetic pathways in colorectal and other cancersEuropean Journal of Cancer, 1999
- Risk biomarkers and current strategies for cancer chemopreventionJournal of Cellular Biochemistry, 1996
- A genetic model for colorectal tumorigenesisCell, 1990